Thalidomide-Then and Now: Case Report of a Woman With Thalidomide Embryopathy and Review of Current Thalidomide Uses.

contraception covid-19 embryopathy gestation man pregnancy sars-cov-2 teratogen thalidomide woman

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Aug 2021
Historique:
accepted: 10 08 2021
entrez: 15 9 2021
pubmed: 16 9 2021
medline: 16 9 2021
Statut: epublish

Résumé

Thalidomide was initially developed as a sedative; subsequently, its use was expanded to treat morning sickness in pregnant women. However, it was later discovered to be a teratogenic drug that was associated with embryopathy in women. A woman is described who was exposed to thalidomide in utero. She had several stigmata of thalidomide embryopathy. Although treatment of nausea and anxiety in pregnant women with thalidomide was discontinued in 1961, the drug has been found to be a useful agent for the management of several systemic conditions and dermatological disorders. Whether the treatment with thalidomide shall be incorporated in the therapeutic regime for patients with severe coronavirus disease 2019 (COVID-19) infection remains to be determined.

Identifiants

pubmed: 34522548
doi: 10.7759/cureus.17070
pmc: PMC8428198
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e17070

Informations de copyright

Copyright © 2021, Malik et al.

Déclaration de conflit d'intérêts

The authors have declared financial relationships, which are detailed in the next section.

Références

Clin Dermatol. 2020 Jul - Aug;38(4):508
pubmed: 32972614
Indian J Dermatol Venereol Leprol. 2018 Sep-Oct;84(5):539-546
pubmed: 29998864
Int J Infect Dis. 2021 Feb;103:507-513
pubmed: 33333254
Exp Ther Med. 2017 Dec;14(6):5251-5257
pubmed: 29285050
Oncotarget. 2016 May 31;7(22):33331-9
pubmed: 27129176
Dermatol Clin. 2010 Jul;28(3):577-86
pubmed: 20510766
PLoS Negl Trop Dis. 2020 Oct 9;14(10):e0008678
pubmed: 33035210
Cochrane Database Syst Rev. 2012 Apr 18;(4):CD008664
pubmed: 22513961
Pharmaceuticals (Basel). 2020 May 13;13(5):
pubmed: 32414180
Dermatol Online J. 2003 Aug;9(3):5
pubmed: 12952752
Dermatol Ther. 2020 Nov;33(6):e14353
pubmed: 32990359
Birth Defects Res C Embryo Today. 2015 Jun;105(2):140-56
pubmed: 26043938
Rev Soc Bras Med Trop. 2020 Sep 11;53:e20190454
pubmed: 32935774
Int J Dermatol. 2005 Jan;44(1):61-7
pubmed: 15663665
Proc Jpn Acad Ser B Phys Biol Sci. 2020;96(6):189-203
pubmed: 32522938
Skinmed. 2020 Aug 01;18(4):254-255
pubmed: 33050993
Acta Dermatovenerol Croat. 2007;15(1):39-44
pubmed: 17433179

Auteurs

Sara Malik (S)

Feinberg School of Medicine, Northwestern University, Chicago, USA.

Philip R Cohen (PR)

Dermatology, University of California, Davis Medical Center, Sacramento, USA.

Classifications MeSH